Interpace Biosciences (IDXG) AGM 2026 summary

Opening remarks and agenda

• The meeting was called to order virtually, with introductions of board members, legal counsel, and the independent auditor present to answer questions.

• The inspector of elections was appointed, and proof of due notice and quorum (95.94% of shares represented) was confirmed.

Shareholder proposals

• Seven proposals were presented: amending the certificate of incorporation, granting authority for a reverse stock split, approving the 2026 equity incentive plan, approving the 2026 employee stock purchase plan, electing directors, a non-binding advisory vote on executive compensation, and ratifying the auditor.

Overview of voting outcomes

• Proposal 1 (amended certificate of incorporation) passed with over 75% approval.

• Proposal 2 (reverse stock split authority) passed by majority.

• Proposal 3 (2026 equity incentive plan) and Proposal 4 (employee stock purchase plan) both passed by majority.

• Proposal 5 resulted in the election of five directors for one-year terms due to board declassification.

• Proposal 6 (executive compensation advisory vote) and Proposal 7 (auditor ratification) both passed by majority.